Company intelligence / Profile preview

Intravacc

Bilthoven, Utrecht, Netherlandsintravacc.nl ↗

Ownership: Private
Employees: ~100
Development stage: Phase 1

Overview

Intravacc has a proven track record in developing and transferring vaccine technologies globally. Its platforms have enabled the development of several marketed childhood disease vaccines. The company supports programs from discovery through Phase I/II clinical trials and has outlicensed multiple vaccine candidates that are now commercialized by partners.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Viral vaccines (including cell-based)Bacterial vaccines (including conjugate and OMV-based)Conjugate vaccinesOuter Membrane Vesicle (OMV) vaccinesTherapeutic vaccines
Industry: Biotech

Drug pipeline

14 assets

haemophilus influenzae b polysaccharide-tetanus conjugate

Approved

13 more assets in the full pipeline.

Request access →

Partnerships

World Health Organization (WHO) – MoUs on polio & influenza capacity buildingDCVMN membersMultiple state-owned/private manufacturers globallyAcademic institutions/universities/research institutesNGOs such as GAVI via Dutch government support

Beyond the preview

Go deeper on Intravacc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intravacc.

Explore the full profile